Stay updated on Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page
- Check4 days agoChange DetectedRevision updated to v3.6.3, replacing the previous v3.6.2 in the study documents section.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.2. This indicates a newer build of the site rather than a modification to the study content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now indicates that enrollment has ended and adds new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with a Revision: v3.6.0 label to reflect the latest update.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a newer revision version (v3.5.5) and no longer shows the previous v3.5.4 revision, reflecting a small software update.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, signaling a new build of the page; there are no visible substantive Content changes to the study details.SummaryDifference0.0%

- Check61 days agoChange DetectedTaiwan location entry updated: Taoyuan District, Taiwan, 333 was removed and Taoyuan, Taiwan, 333 was added, reflecting a rename/relocation in the study's locations list.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.